Logo image of PQG

Pq Group Holdings Inc (PQG) Stock Fundamental Analysis

NYSE:PQG - New York Stock Exchange, Inc. -

15.65  +0.09 (+0.58%)

After market: 15.65 0 (0%)

Fundamental Rating

1

Taking everything into account, PQG scores 1 out of 10 in our fundamental rating. PQG was compared to 85 industry peers in the Chemicals industry. PQG may be in some trouble as it scores bad on both profitability and health. PQG is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

In the past year PQG was profitable.

1.2 Ratios

Industry RankSector Rank
ROA -12.13%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Industry RankSector Rank
OM -15.55%
PM (TTM) -33.53%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

1

2. Health

2.1 Basic Checks

There is no outstanding debt for PQG. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

PQG has an Altman-Z score of 0.68. This is a bad value and indicates that PQG is not financially healthy and even has some risk of bankruptcy.
PQG has a Debt/Equity ratio of 1.18. This is a high value indicating a heavy dependency on external financing.
Industry RankSector Rank
Debt/Equity 1.18
Debt/FCF N/A
Altman-Z 0.68
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

A Current Ratio of 1.92 indicates that PQG should not have too much problems paying its short term obligations.
PQG has a Quick Ratio of 1.66. This is a normal value and indicates that PQG is financially healthy and should not expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 1.92
Quick Ratio 1.66

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 11.46% over the past year.
The Earnings Per Share has been growing by 16.95% on average over the past years. This is quite good.
The Revenue for PQG has decreased by -29.37% in the past year. This is quite bad
PQG shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 23.28% yearly.
EPS 1Y (TTM)11.46%
EPS 3Y16.95%
EPS 5YN/A
EPS Q2Q%-75%
Revenue 1Y (TTM)-29.37%
Revenue growth 3Y-9.05%
Revenue growth 5Y23.28%
Sales Q2Q%-64.98%

3.2 Future

PQG is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -0.42% yearly.
The Revenue is expected to decrease by -12.69% on average over the next years. This is quite bad
EPS Next Y-66.05%
EPS Next 2Y-28.34%
EPS Next 3Y-11.56%
EPS Next 5Y-0.42%
Revenue Next Year-58.82%
Revenue Next 2Y-33.24%
Revenue Next 3Y-22.79%
Revenue Next 5Y-12.69%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
PQG Yearly Revenue VS EstimatesPQG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B
PQG Yearly EPS VS EstimatesPQG Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

1

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 14.63, the valuation of PQG can be described as correct.
When comparing the Price/Earnings ratio of PQG to the average of the S&P500 Index (29.62), we can say PQG is valued rather cheaply.
A Price/Forward Earnings ratio of 25.61 indicates a quite expensive valuation of PQG.
PQG's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 22.70.
Industry RankSector Rank
PE 14.63
Fwd PE 25.61
PQG Price Earnings VS Forward Price EarningsPQG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -79.78
PQG Per share dataPQG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

A cheap valuation may be justified as PQG's earnings are expected to decrease with -11.56% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-28.34%
EPS Next 3Y-11.56%

0

5. Dividend

5.1 Amount

PQG does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

Pq Group Holdings Inc

NYSE:PQG (8/2/2021, 8:26:23 PM)

After market: 15.65 0 (0%)

15.65

+0.09 (+0.58%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0%
Inst Owner Change-91.97%
Ins Owners1.58%
Ins Owner Change0%
Market Cap2.14B
Analysts85
Price Target19.07 (21.85%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 14.63
Fwd PE 25.61
P/S 1.93
P/FCF N/A
P/OCF N/A
P/B 1.81
P/tB N/A
EV/EBITDA -79.78
EPS(TTM)1.07
EY6.84%
EPS(NY)0.61
Fwd EY3.9%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS8.1
BVpS8.67
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -12.13%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM -15.55%
PM (TTM) -33.53%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.36
Health
Industry RankSector Rank
Debt/Equity 1.18
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.92
Quick Ratio 1.66
Altman-Z 0.68
F-Score2
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)11.46%
EPS 3Y16.95%
EPS 5YN/A
EPS Q2Q%-75%
EPS Next Y-66.05%
EPS Next 2Y-28.34%
EPS Next 3Y-11.56%
EPS Next 5Y-0.42%
Revenue 1Y (TTM)-29.37%
Revenue growth 3Y-9.05%
Revenue growth 5Y23.28%
Sales Q2Q%-64.98%
Revenue Next Year-58.82%
Revenue Next 2Y-33.24%
Revenue Next 3Y-22.79%
Revenue Next 5Y-12.69%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A